Overview This page contains the latest trade data of Amino-aldehydes, amino-ketones and amino-quinones: other than those containing more than one kind of oxygen function: salts thereof, excluding amfepramone (INN), methadone (INN), and normethadone (INN) and salts thereof. In 2022, Amino-aldehydes, amino-ketones and amino-quinones: other than those containing more than one kind of oxygen function: salts thereof, excluding amfepramone (INN), methadone (INN), and normethadone (INN) and salts thereof were the world's 3830th most traded product, with a total trade of $213M. Between 2021 and 2022 the exports of Amino-aldehydes, amino-ketones and amino-quinones: other than those containing more than one kind of oxygen function: salts thereof, excluding amfepramone (INN), methadone (INN), and normethadone (INN) and salts thereof grew by 9.82%, from $194M to $213M. Trade in Amino-aldehydes, amino-ketones and amino-quinones: other than those containing more than one kind of oxygen function: salts thereof, excluding amfepramone (INN), methadone (INN), and normethadone (INN) and salts thereof represent 0.0009% of total world trade.
Amino-aldehydes, amino-ketones and amino-quinones: other than those containing more than one kind of oxygen function: salts thereof, excluding amfepramone (INN), methadone (INN), and normethadone (INN) and salts thereof are a part of Oxygen-function amino-compounds.
Exports In 2022 the top exporters of Amino-aldehydes, amino-ketones and amino-quinones: other than those containing more than one kind of oxygen function: salts thereof, excluding amfepramone (INN), methadone (INN), and normethadone (INN) and salts thereof were China ($69.1M), India ($59.2M), Italy ($22.9M), Germany ($22.6M), and Spain ($15.8M).
Imports In 2022 the top importers of Amino-aldehydes, amino-ketones and amino-quinones: other than those containing more than one kind of oxygen function: salts thereof, excluding amfepramone (INN), methadone (INN), and normethadone (INN) and salts thereof were United States ($42.2M), India ($23M), Canada ($17.4M), Italy ($10.8M), and Peru ($10.2M).
Ranking Amino-aldehydes, amino-ketones and amino-quinones: other than those containing more than one kind of oxygen function: salts thereof, excluding amfepramone (INN), methadone (INN), and normethadone (INN) and salts thereof ranks 3249th in the Product Complexity Index (PCI).